How tumor-infiltrating T lymphocytes (TILs) adapt to the metabolic constrains within the tumor microenvironment (TME) and to what degree this affects their ability to combat tumor progression remain poorly understood. Using mouse melanoma models, we report that CD8+ TILs enhance peroxisome proliferator-activated receptor (PPAR)-α signaling and catabolism of fatty acids (FAs) when simultaneously subjected to hypoglycemia and hypoxia. This metabolic switch partially preserves CD8+ TILs' effector functions, although co-inhibitor expression increases during tumor progression regardless of CD8+ TILs' antigen specificity. Further promoting FA catabolism improves the CD8+ TILs' ability to slow tumor progression. PD-1 blockade delays tumor growth without changing TIL metabolism or functions. It synergizes with metabolic reprogramming of T cells to achieve superior antitumor efficacy and even complete cures.
Pubmed ID: 28898698 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets CD31
View all literature mentionsThis monoclonal targets Bromodeoxyuridine
View all literature mentionsThis isotype control targets Trinitrophenol
View all literature mentionsThis monoclonal targets AKT1
View all literature mentionsThis monoclonal targets HIF-1
View all literature mentionsThis monoclonal targets Glucose Transporter GLUT1
View all literature mentionsThis monoclonal targets Mouse IgG2b, kappa Isotype Control
View all literature mentionsThis monoclonal targets CPT1A
View all literature mentionsThis monoclonal targets CD62L
View all literature mentionsThis monoclonal targets
View all literature mentionsThis unknown targets Mouse IgG1 Alexa Fluor 700 Isotype Control (Clone 11711)
View all literature mentionsThis polyclonal targets Human PPAR alpha (Biotin)
View all literature mentionsThis unknown targets IgG (H+L)
View all literature mentionsThis monoclonal targets FoxO1 (C29H4) Rabbit mAb
View all literature mentionsThis monoclonal targets Perforin
View all literature mentionsThis monoclonal targets Granzyme B
View all literature mentionsThis monoclonal targets IFN-gamma
View all literature mentionsThis monoclonal targets IFN-gamma
View all literature mentionsThis monoclonal targets EOMES
View all literature mentionsThis monoclonal targets T-bet
View all literature mentionsThis monoclonal targets CD279
View all literature mentionsThis monoclonal targets Human CCR7
View all literature mentionsThis monoclonal targets CD95 (Fas)
View all literature mentionsThis unknown targets CD28
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD14
View all literature mentionsThis monoclonal targets Human CD8
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD45.1
View all literature mentionsThis monoclonal targets CD90/CD90.1
View all literature mentionsThis monoclonal targets CD90/CD90.1
View all literature mentionsThis monoclonal targets TCR Valpha2
View all literature mentionsThis monoclonal targets KLRG1
View all literature mentionsThis monoclonal targets CD62L
View all literature mentionsThis monoclonal targets CD127
View all literature mentionsThis monoclonal targets CD127
View all literature mentionsThis monoclonal targets CD223
View all literature mentionsThis monoclonal targets CD223
View all literature mentionsThis unknown targets Rat IgG2b kappa Isotype Control Allophycocyanin Clone RTK4530
View all literature mentionsThis unknown targets Rat IgG2b kappa Isotype Control PE / Cyanine 7 Clone RTK4530
View all literature mentionsThis monoclonal targets CD274
View all literature mentionsThis monoclonal targets CD279
View all literature mentionsThis monoclonal targets CD279
View all literature mentionsThis monoclonal targets CD44
View all literature mentionsThis monoclonal targets CD44
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD28
View all literature mentionsThis monoclonal targets CD3e
View all literature mentionsSoftware for single-cell flow cytometry analysis. Its functions include management, display, manipulation, analysis and publication of the data stream produced by flow and mass cytometers.
View all literature mentionsStatistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.
View all literature mentionsCell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)
View all literature mentions
Mus musculus with name NOD.Cg-Prkdcscid Il2rg
Mus musculus with name C57BL/6-Tg(TcraTcrb)1100Mjb/J from IMSR.
View all literature mentionsMus musculus with name 129S4/SvJae-Pparatm1Gonz/J from IMSR.
View all literature mentionsMus musculus with name B6.PL-Thy1a/CyJ from IMSR.
View all literature mentionsMus musculus with name B6.SJL-Ptprca Pepc/BoyJ from IMSR.
View all literature mentionsMus musculus with name C57BL/6J from IMSR.
View all literature mentionsCell line HEK293 is a Transformed cell line with a species of origin Homo sapiens (Human)
View all literature mentions